# AristaMD

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aristamd

- Industry: Healthcare IT
- Headquarters: San Diego, US
- Website: www.aristamd.com/
- Total disclosed funding: $33M
- Latest round: Series B (Jul 14, 2020)
- Investors on record: 8

## About

Based in San Diego, California, AristaMD, Inc. is a technology-driven clinical services provider focused on enhancing access to specialty care for primary care physicians and their patients through innovative solutions.AristaMD, Inc. specializes in technology-enabled clinical services that improve access to specialty care. Founded in 2014 in San Diego, California, the company has completed 13 deals, with its most recent funding round being a Series C totaling USD 17.053 mn on November 2, 2023. The company is led by CEO Brooke Levasseur.AristaMD provides a technology-enabled clinical services suite called SpecialtyCare 360. This includes eConsults, telehealth services, and care management solutions aimed at improving care delivery and outcomes while reducing costs. The suite addresses issues like long wait times and lack of treatment plans for PCPs, serving thousands of healthcare providers across the United States, and includes specialties such as cardiology and rheumatology.AristaMD operates on a B2B model, generating revenue through subscription-based services offered to healthcare organizations. Clients, including primary care practices, pay for access to the SpecialtyCare 360 suite, facilitating efficient consultations between PCPs and specialists. This structured pricing model allows clients to tailor packages to fit their specific needs, with revenue primarily coming from partnerships with healthcare providers.In November 2023, AristaMD, Inc. raised USD 17.05 mn in Series C funding, which will be directed towards supporting business expansion. The company aims to introduce new products and enhance its market presence, targeting specific geographic regions for growth. Further details on product launches or specific areas for market entry have not been disclosed.

## Funding rounds

- Series B, Jul 14, 2020, $8M — .406 Ventures, Ascension Ventures, MemorialCare Innovation Fund, Cigna Ventures
- Series B, Mar 31, 2020, $14M — Avalon Ventures, MemorialCare Innovation Fund, Stanford Health Care, Cigna Ventures, CU Healthcare Innovation Fund
- Series A, Jul 21, 2016, $11M — Avalon Ventures, Correlation Ventures

## Investors

- Avalon Ventures (https://capitalatlas.ai/funds/avalon-ventures) — Series A, Series B
- Correlation Ventures (https://capitalatlas.ai/funds/correlation-ventures) — Series A
- MemorialCare Innovation Fund (https://capitalatlas.ai/funds/memorialcare-innovation-fund) — Series B
- Stanford Health Care — Series B
- Cigna Ventures (https://capitalatlas.ai/funds/cigna-ventures) — Series B
- CU Healthcare Innovation Fund (https://capitalatlas.ai/funds/cu-healthcare-innovation-fund) — Series B
- .406 Ventures (https://capitalatlas.ai/funds/406-ventures) — Series B
- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series B